Pathology & Oncology Research

, Volume 25, Issue 1, pp 249–254 | Cite as

Multidetector Computed Tomographic Urography (MDCTU): Its Practical Role in Diagnosis of Upper Tract Urothelial Cancer in Patients 50 years and Older with Different Types of Hematuria

  • Sergey KravchickEmail author
  • Eugenia Cherniavsky
  • Guy Verchovsky
  • Ronit Peled
Original Article


MDCTU is a preferred method for the investigation of malignant lesions in the upper urinary tract. However, to decrease unnecessary radiation exposure the indications for the exam in different groups of patients should be assessed. In this study, we evaluated the role of MDCTU in patients older than 50 years who presented with different types of hematuria. In a retrospective manner, we assessed the radiologic reports of 173 patients ≥50 years who underwent MDCTU as a part of the evaluation for hematuria. To estimate the accuracy of MDCTU in the detection of upper urinary tract urothelial carcinoma (UUTUC) we compared MDCTU findings with the results of ureteroscopy. We also evaluated which factors can predict ureteroscopic confirmation of MDCTU-based diagnosis. In this list we also included diabetes mellitus and anticoagulant medications. As a result, 140 (103 males and 37 females) patients met the inclusion criteria. Mean patients' age was 69.7±16.98. Smokers and passive smokers comprised 38.6% and 26.4% of our patients, while 37.8% of our patients suffered from DM and 45% took anticoagulant medications. MDCTU suspected urothelial carcinoma in 17% (n=24) of our patients: UUTUC in eight and bladder urothelial carcinoma (BUC) in 16patients. Ureteroscopy had diagnosed UUTUC (with/without concurrent urothelial carcinoma of the bladder) in 9 patients: 6 with suspicious lesions in MDCTU and 3 additional patients with CIS/small low grade TCC. MDCTU had a sensitivity of 66.7%, specificity - 98.5%, positive predictive value - 75% and negative predictive value - 97.7%. The logistic regression model revealed five strong predictors for UUTUC: positive/atypical cytology, recurrent hematuria, MDCTU signs, age and Warfarin treatment. Finally a source of hematuria was diagnosed in 57% of patients, while MDCTU individual accuracy reached 42%. We found that MDCTU can effectively identify patients in whom further endoscopy is unnecessary. Otherwise, elder patients with positive/atypical cytology and recurrent microscopic hematuria, who have MDCTU signs and take Warfarin, should undergo endoscopic evaluation.


Upper tract TCC Computer tomography Urography Hematuria Ureteroscopy 


  1. 1.
    Munoz JJ, Ellison LM (2000) Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol 164(5):1523–1525Google Scholar
  2. 2.
    Roupreˆt M, Babjuk M, Compérat E et al (2013) European guidelines on upper tract urothelial carcinomas: 2013 update. Eur Urol 63:1059–1071CrossRefGoogle Scholar
  3. 3.
    Babjuk M, Burger M, Zigeuner R et al (2013) EAU guidelines on non–muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol 64:639–653CrossRefGoogle Scholar
  4. 4.
    Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10–29CrossRefGoogle Scholar
  5. 5.
    Roupreˆt M, Babjuk M, Compérat E, Zigeuner R et al (2015) European Association of Urology guidelines on upper urinary tract urothelial cell carcinoma: 2015 update. Eur Urol 68:868–879CrossRefGoogle Scholar
  6. 6.
    Azemar MD, Comperat E, Richard F, Cussenot O, Roupret M (2011) Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: frequency, risk factors, and surveillance. Urol Oncol 29(2):130–136CrossRefGoogle Scholar
  7. 7.
    Raman JD, Ng CK, Scherr DS et al (2010) Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical Nephroureterectony. Eur Urol 57(6):1072–1079CrossRefGoogle Scholar
  8. 8.
    Li WM, Shen JT, Li CC et al (2010) Oncologic outcomes following three different Aproaches to the distal ureter and bladder cuff in Nephroureterectomy for primary upper urinary tract urothelial carcinoma. Eur Urol 57(6):963–969CrossRefGoogle Scholar
  9. 9.
    Margulis V, Shariat SF, Matin SF et al (2009) Outcomes of radical nephroureterectomy: a series from the upper tract urothelial carcinoma collaboration. Cancer 115(6):1224–1233CrossRefGoogle Scholar
  10. 10.
    Van Der Molen AJ, Cowan NC, Mueller-Lisse UG et al (2008) CT urography: definition, indications and techniques. A guideline for clinical practice. Eur Radiol 18(1):4–17CrossRefGoogle Scholar
  11. 11.
    Wang LJ, Wong YC, Chuang CK et al (2009) Diagnostic accuracy of transitional cell carcinoma on multidetector computerized tomography urography in patients with gross hematuria. J Urol 181(2):524–531CrossRefGoogle Scholar
  12. 12.
    Wang LJ, Wong YC, Huang CC et al (2010) Multidetector computerized tomography urography is more accurate than excretory urography for diagnosing transitional cell carcinoma of the upper tract in adults with hematuria. J Urol 183(1):48–55CrossRefGoogle Scholar
  13. 13.
    Caoili EM, Cohan RH, Korobkin M et al (2002) Urinary tract abnormalities: initial experience with multi-detector row CT urography. Radiology 222:353–360CrossRefGoogle Scholar
  14. 14.
    Chlapoutakis K, Theocharopoulos N, YarmenitisS DJ (2010) Performance of computed tomographic urography in diagnosis of upper urinary tract urothelial carcinoma, in patients presenting with hematuria: systematic review and meta-analysis. Eur J Radiol 73:334–338CrossRefGoogle Scholar
  15. 15.
    Loo RK, Lieberman SF, Slezak JM et al (2013) Stratifying risk of urinary tract malignant tumors in patients with asymptomatic microscopic hematuria. Mayo Clin Proc 88(2):129–138CrossRefGoogle Scholar
  16. 16.
    O’Connor OJ, McSweeney SE, Maher MM (2008) Imaging of hematuria. Radiol Clin N Am 46:113–132CrossRefGoogle Scholar
  17. 17.
    Edwards TJ, Dickinson AJ, Natale S, Gosling J, McGrath JS (2006) A prospective analysis of the diagnostic yield resulting from the attendance of 4020 patients at a protocol-driven haematuria clinic. BJU Int 97:301–305CrossRefGoogle Scholar
  18. 18.
    Cauberg EC1, Nio CY, de la Rosette JM, Laguna MP, de Reijke TM (2011) Computed tomography-urography for upper urinary tract imaging: is it required for all patients who present with hematuria? J Endourol 25(11):1733–1740Google Scholar
  19. 19.
    Lisanti CJ1, Toffoli TJ, Stringer MT, DeWitt RM, Schwope RB (2014) CT evaluation of the upper urinary tract in adults younger than 50 years with asymptomatic microscopic hematuria: is IV contrast enhancement needed? AJR Am J Roentgenol 203(3):615–619Google Scholar
  20. 20.
    Raman SP, Horton KM, Fishman EK (2012) Transitional cell carcinoma of the upper urinary tract: optimizing image interpretation with 3D reconstructions. Abdom Imaging 37:1129–1140CrossRefGoogle Scholar
  21. 21.
    Johnson PT, Horton KM, Fishman EK (2010) Optimizing detectability of renal pathology with MDCT: protocols, pearls, and pitfalls. AJR 194:1001–1012CrossRefGoogle Scholar
  22. 22.
    Woolcott CG1, Maskarinec G, Haiman CA, Henderson BE, Kolonel LN (2011) Diabetes and urothelial cancer risk: the multiethnic cohort study. Cancer Epidemiol 35(6):551–554Google Scholar
  23. 23.
    Jung H, Gleason JM, Loo RK et al (2011) Association of hematuria on microscopic urinalysis and risk of urinary tract cancer. J Urol 185(5):1698–1703CrossRefGoogle Scholar
  24. 24.
    Munoz JJ, Ellison LM (2000) Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol 164:1523–1525CrossRefGoogle Scholar
  25. 25.
    van Osch FH, Jochems SH, van Schooten FJ, Bryan RT, Zeegers MP (2016) Significant role of lifetime cigarette smoking in worsening bladder cancer and upper tract urothelial carcinoma prognosis: a meta-analysis. J Urol 195(4):872–879CrossRefGoogle Scholar
  26. 26.
    Caoili EM, Cohan RH, Inampudi P et al (2005) MDCT urography of upper tract urothelial neoplasms. AJR 184:1873–1881CrossRefGoogle Scholar
  27. 27.
    Xu AD, Ng CS, Kamat A, Grossman HB, Dinney C, Sandler CM (2010) Significance of upper urinary tract urothelial thickening and filling defect seen on MDCT urography in patients with a history of urothelial neoplasms. AJR 195:959–965CrossRefGoogle Scholar
  28. 28.
    Browne RF, Meehan CP, Colville J, Power R, Torreggiani WC (2005) Transitional cell carcinoma of the upper urinary tract: spectrum of imaging findings. Radiographics 25:1609–1627CrossRefGoogle Scholar
  29. 29.
    Xu AD1, Ng CS, Kamat A, Grossman HB, Dinney C, Sandler CM (2010) Significance of upper urinary tract urothelial thickening and filling defect seen on MDCT urography in patients with a history of urothelial neoplasms. AJR Am J Roentgenol 195(4):959–965Google Scholar
  30. 30.
    Khadra MH, Pickard RS, Charlton M et al (2000) A prospective analysis of 1,930 patients with hematuria to evaluate current diagnostic practice. J Urol 163(2):524–527CrossRefGoogle Scholar

Copyright information

© Arányi Lajos Foundation 2017

Authors and Affiliations

  1. 1.Department of UrologyAssaf Harofeh Medical CenterZrefinIsrael
  2. 2.Department of UrologyBarzilai Medical CenterAshkelonIsrael
  3. 3.Department of RoentgenologyBarzilai Medical CenterAshkelonIsrael
  4. 4.Epidemiology and StatisticsBen Gurion UniversityBeershebaIsrael

Personalised recommendations